ATE342999T1 - Auf siv basierende verpackungsdefiziente vektoren - Google Patents

Auf siv basierende verpackungsdefiziente vektoren

Info

Publication number
ATE342999T1
ATE342999T1 AT00940511T AT00940511T ATE342999T1 AT E342999 T1 ATE342999 T1 AT E342999T1 AT 00940511 T AT00940511 T AT 00940511T AT 00940511 T AT00940511 T AT 00940511T AT E342999 T1 ATE342999 T1 AT E342999T1
Authority
AT
Austria
Prior art keywords
siv
vectors
deficiency
based packaging
packaging
Prior art date
Application number
AT00940511T
Other languages
English (en)
Inventor
Andrew Lever
Jane Greatorex
Eamon Mccann
Preetha Balan
Joan Thomas
Original Assignee
Univ Cambridge Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9913459.5A external-priority patent/GB9913459D0/en
Priority claimed from GBGB9916911.2A external-priority patent/GB9916911D0/en
Application filed by Univ Cambridge Tech filed Critical Univ Cambridge Tech
Application granted granted Critical
Publication of ATE342999T1 publication Critical patent/ATE342999T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packaging Of Special Articles (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT00940511T 1999-06-09 2000-06-09 Auf siv basierende verpackungsdefiziente vektoren ATE342999T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9913459.5A GB9913459D0 (en) 1999-06-09 1999-06-09 Defective packaging non-oncoviral vectors
GBGB9916911.2A GB9916911D0 (en) 1999-07-19 1999-07-19 Defective packaging non-oncoviral vectors

Publications (1)

Publication Number Publication Date
ATE342999T1 true ATE342999T1 (de) 2006-11-15

Family

ID=26315654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940511T ATE342999T1 (de) 1999-06-09 2000-06-09 Auf siv basierende verpackungsdefiziente vektoren

Country Status (7)

Country Link
EP (1) EP1183383B1 (de)
JP (1) JP2003501066A (de)
AT (1) ATE342999T1 (de)
AU (1) AU5543700A (de)
CA (1) CA2376790A1 (de)
DE (1) DE60031398D1 (de)
WO (1) WO2000075351A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248083A1 (en) * 2001-05-17 2004-12-09 Mikkelsen Jacob Giehm Vectors for gene therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048277A1 (en) * 1996-06-20 1997-12-24 The Salk Institute For Biological Studies Modular assembly retroviral vectors and uses thereof
AU8576298A (en) * 1997-07-18 1999-02-10 Chiron Corporation Lentiviral vectors

Also Published As

Publication number Publication date
JP2003501066A (ja) 2003-01-14
EP1183383B1 (de) 2006-10-18
DE60031398D1 (de) 2006-11-30
AU5543700A (en) 2000-12-28
WO2000075351A1 (en) 2000-12-14
EP1183383A1 (de) 2002-03-06
CA2376790A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
ATE291632T1 (de) Auf lentivirus basierende gentransfer-vektoren
ATE243260T1 (de) Adenovirus helfervirus system
YU79092A (sh) Direktno molekularno klonirnje modofikovanog eukariotičnog citoplazmatičnog dnk virusnog genoma
DE69739870D1 (de) Verbesserte adenovirusvektoren
IE800991L (en) HBs Ag GENE AND PRODUCT
MX9702553A (es) Adenovirus libres de particulas contaminantes viables, su preparacion y su uso.
EP0953648A3 (de) Bei einer transkomplementenden Zellinie erzeugter defektiver Virenimpfstoff
ATE270342T1 (de) Endosomolytisch wirksame partikel
Deng et al. Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68
CA2439067A1 (en) Lentiviral packaging constructs
ATE454039T1 (de) Verfharen zur herstellung von herpes-simplex- virus-amplikons, die resultierenden amplikons und ihre verwendung
ATE342999T1 (de) Auf siv basierende verpackungsdefiziente vektoren
ATE342997T1 (de) Herpesvirus saimiri als viraler vektor
WO2000040741A3 (en) Lentivirus vector system
WO2002096939A3 (en) Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
CA2099268A1 (en) Fusions of a viral protein and a destructive enzyme
Manrique et al. Mutational analysis of the feline immunodeficiency virus matrix protein
WO2002079464A3 (en) Viral vectors
WO2002008436A3 (en) Mini-adenoviral vector system for vaccination
WO2001044458A3 (en) Bovine immunodeficiency virus (biv) based vectors
GB0318704D0 (en) Chimaeric vector system
AU8188187A (en) Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained
Bansal et al. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env
Fang et al. A packaging system for SV40 vectors without viral coding sequences
WO1995025806A3 (en) Packaging-deficient lentiviruses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties